kynurenine has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acuña-Castroviejo, D | 1 |
| Tapias, V | 1 |
| López, LC | 1 |
| Doerrier, C | 1 |
| Camacho, E | 1 |
| Carrión, MD | 1 |
| Mora, F | 1 |
| Espinosa, A | 1 |
| Escames, G | 1 |
1 other study available for kynurenine and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Cytosol; Disease Models, Ani | 2011 |